Tilray | TRLY - أصول متداولة





أصول متداولة تغيير تاريخ
Acasti Pharma USD 17.3M 3.22M 2025-09
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Aurora Cannabis CAD 445.84M 22M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Canopy Growth CAD 524.67M 78.85M 2025-12
Cronos Group USD 927.88M 16.21M 2026-03
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Moderna USD 5.77B 774M 2026-03
Organigram Holdings CAD 256.54M 28.35M 2025-12
Organon & Co USD 4.93B 580M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03
Zealand Pharma A/S 15.67B 950.94M 2025-12